DNA (Ginkgo Bioworks Holdings, Inc.)
Insider Trading Activity
Every open-market purchase and sale reported by DNA officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-25 | Steven P. Coen | See remarks | MIXED | — | — |
| 2026-07-30 | Reshma P. Shetty | See remarks | A | — | — |
| 2026-07-30 | Barry Canton | 10%+ Owner | A | — | — |
| 2026-07-30 | Jason R Kelly | See remarks | A | — | — |
| 2026-07-20 | Steven P. Coen | See remarks | MIXED | — | — |
| 2026-06-15 | Sri Kosuri | Director | A | — | — |
| 2026-06-15 | HARRY SLOAN | Director | A | — | — |
| 2026-06-15 | CHRISTIAN O HENRY | Director | A | — | — |
| 2026-06-15 | Ross Fubini | Director | A | — | — |
| 2026-05-26 | Steven P. Coen | See remarks | MIXED | — | — |
| 2026-04-20 | Steven P. Coen | See remarks | MIXED | — | — |
| 2026-04-14 | Steven P. Coen | See remarks | MIXED | — | — |
| 2026-04-13 | Barry Canton | 10%+ Owner | MIXED | — | — |
| 2026-04-13 | Reshma P. Shetty | See remarks | MIXED | — | — |
| 2026-04-10 | Reshma P. Shetty | See remarks | MIXED | — | — |
| 2026-04-10 | Barry Canton | 10%+ Owner | MIXED | — | — |
| 2026-04-10 | Jason R Kelly | See remarks | MIXED | — | — |
| 2026-03-18 | Steven P. Coen | See remarks | MIXED | — | — |
| 2026-01-22 | Steven P. Coen | See remarks | MIXED | — | — |
| 2025-12-16 | Steven P. Coen | See remarks | MIXED | — | — |
| 2025-10-21 | Steven P. Coen | See remarks | MIXED | — | — |
| 2025-10-03 | Steven P. Coen | See remarks | Sell | — | — |
| 2025-09-10 | CHRISTIAN O HENRY | Director | Sell | — | — |
| 2025-08-26 | Steven P. Coen | See remarks | MIXED | — | — |
| 2025-07-21 | Steven P. Coen | See remarks | MIXED | — | — |
| 2025-06-13 | Shyam Sankar | Director | M | — | — |
| 2025-06-13 | Kathy Hopinkah Hannan | Director | M | — | — |
| 2025-06-13 | Sri Kosuri | Director | M | — | — |
| 2025-06-13 | HARRY SLOAN | Director | M | — | — |
| 2025-06-13 | CHRISTIAN O HENRY | Director | M | — | — |
| 2025-06-13 | MYRTLE S POTTER | Director | M | — | — |
| 2025-06-13 | Ross Fubini | Director | M | — | — |
| 2025-05-22 | Mark E. Dmytruk | See remarks | MIXED | — | — |
| 2025-05-22 | Steven P. Coen | See remarks | MIXED | — | — |
| 2025-04-23 | Mark E. Dmytruk | See remarks | MIXED | — | — |
| 2025-04-23 | Steven P. Coen | See remarks | MIXED | — | — |
| 2025-03-17 | Mark E. Dmytruk | See remarks | C | — | — |
| 2025-03-10 | Mark E. Dmytruk | See remarks | A | — | — |
| 2025-03-10 | Steven P. Coen | See remarks | A | — | — |
| 2025-03-06 | Mark E. Dmytruk | See remarks | MIXED | — | — |
| 2025-03-06 | Steven P. Coen | See remarks | MIXED | — | — |
| 2025-02-06 | Mark E. Dmytruk | See remarks | MIXED | — | — |
| 2025-02-06 | Steven P. Coen | See remarks | MIXED | — | — |
| 2025-01-08 | Steven P. Coen | See remarks | MIXED | — | — |
| 2025-01-08 | Mark E. Dmytruk | See remarks | MIXED | — | — |
| 2024-12-13 | HARRY SLOAN | Director | J | — | — |
| 2024-12-05 | Mark E. Dmytruk | See remarks | MIXED | — | — |
| 2024-12-05 | Steven P. Coen | See remarks | MIXED | — | — |
| 2024-11-22 | HARRY SLOAN | Director | J | — | — |
| 2024-11-08 | Sri Kosuri | Director | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | See remarks | 898,250 | — |
| — | 10%+ Owner | 801,261 | — |
| — | See remarks | 310,316 | — |
| — | Director | 271,418 | — |
| — | Director | 72,372 | — |
| — | See remarks | 52,025 | — |
| — | See remarks | 46,226 | — |
| — | Director | 34,310 | — |
| — | Director | 24,067 | — |
| — | Director | 15,003 | — |
| — | Director | 10,822 | — |
| — | Director | 10,822 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the DNA quote page; the site-wide leaderboard is on the insider transactions hub.